<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016063"><a href="http://purl.obolibrary.org/obo/MONDO_0016063">MONDO:0016063</a></h3>
<p><strong>Label:</strong> Cowden disease</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0008021">MONDO:0008021</a> (Cowden syndrome 1),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_201">Orphanet:201</a>, <a href="http://www.orpha.net/ORDO/Orphanet_65285">Orphanet:65285</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2969">Orphanet:2969</a>, <a href="http://purl.obolibrary.org/obo/OMIM_158350">OMIM:158350</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0200036">HP:0200036</a> (Skin nodule) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0100568">HP:0100568</a> (Neoplasm of the endocrine system) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0100031">HP:0100031</a> (Neoplasm of the thyroid gland) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0040194">HP:0040194</a> (Increased head circumference) and <a href="http://purl.obolibrary.org/obo/HP_0200036">HP:0200036</a> (Skin nodule) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0040194">HP:0040194</a> (Increased head circumference) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0040064">HP:0040064</a> (Abnormality of limbs) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0030809">HP:0030809</a> (Abnormal tongue morphology) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0012243">HP:0012243</a> (Abnormal reproductive system morphology) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0011772">HP:0011772</a> (Abnormality of thyroid morphology) and <a href="http://purl.obolibrary.org/obo/HP_0200016">HP:0200016</a> (Acrokeratosis) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010619">HP:0010619</a> (Fibroadenoma of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0011368">HP:0011368</a> (Epidermal thickening) and <a href="http://purl.obolibrary.org/obo/HP_0200036">HP:0200036</a> (Skin nodule) 75.00%</li>
</ul>
</body>
</html>
